Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

SELL
$47.98 - $54.4 $15,209 - $17,244
-317 Reduced 4.14%
7,348 $398 Million
Q4 2023

Jan 26, 2024

BUY
$48.48 - $57.85 $371,599 - $443,420
7,665 New
7,665 $393 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $121B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Harbour Trust & Investment Management CO Portfolio

Follow Harbour Trust & Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Trust & Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Harbour Trust & Investment Management CO with notifications on news.